# A Study To Investigate The Safety, Tolerability And Blood Levels Of GSK598809

> **NCT00437840** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 12 (actual)

## Conditions studied

- Substance Dependence

## Interventions

- **DRUG:** GSK598809
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00437840
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03-20
- **Primary completion:** 2007-06-20
- **Final completion:** 2007-06-20
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00437840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00437840, "A Study To Investigate The Safety, Tolerability And Blood Levels Of GSK598809". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00437840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*